General Information of the Compound
| Compound ID |
CP0487351
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(E)-N-[(4R,4aR,7R,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(3-nitrophenyl)prop-2-enamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H27N3O5
|
||||||||||||||||||
| Molecular Weight |
473.529
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc2C[C@@H]3[C@@H]4C=C[C@@H](NC(=O)\C=C\c5cccc(c5)[N+]([O-])=O)[C@@H]5Oc1c2[C@]45CCN3C
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H27N3O5/c1-29-13-12-27-19-8-9-20(28-23(31)11-6-16-4-3-5-18(14-16)30(32)33)26(27)35-25-22(34-2)10-7-17(24(25)27)15-21(19)29/h3-11,14,19-21,26H,12-13,15H2,1-2H3,(H,28,31)/b11-6+/t19-,20+,21+,26-,27-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BDSJWYGNIYCHQA-PWGNIBDOSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01791, Delta-type opioid receptor
Protein ID: PT02264, Kappa-type opioid receptor
Protein ID: PT02699, Mu-type opioid receptor